113 related articles for article (PubMed ID: 15033622)
1. The use of clopidogrel in patients with coronary artery disease.
Cavuşoğlu E
Anadolu Kardiyol Derg; 2004 Mar; 4(1):63-72. PubMed ID: 15033622
[TBL] [Abstract][Full Text] [Related]
2. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
Motovska Z; Kala P
Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
[TBL] [Abstract][Full Text] [Related]
3. Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.
Duzenli MA; Ozdemir K; Aygul N; Soylu A; Tokac M
Am J Cardiol; 2008 Aug; 102(4):396-400. PubMed ID: 18678294
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet agents and the role of clopidogrel in the prevention of secondary atherosclerotic events.
Jackson A; Luisi AF
Med Health R I; 1999 Aug; 82(8):297-9. PubMed ID: 10472145
[No Abstract] [Full Text] [Related]
5. Clopidogrel use in coronary artery disease.
Baggish AL; Sabatine MS
Expert Rev Cardiovasc Ther; 2006 Jan; 4(1):7-15. PubMed ID: 16375623
[TBL] [Abstract][Full Text] [Related]
6. Variable response to clopidogrel in patients with coronary artery disease.
Geisler T; Gawaz M
Semin Thromb Hemost; 2007 Mar; 33(2):196-202. PubMed ID: 17340469
[TBL] [Abstract][Full Text] [Related]
7. The role of clopidogrel in the management of patients with ischemic heart disease.
Chopra V; Marmur JD; Cavusoglu E
Cardiovasc Drugs Ther; 2003; 17(5-6):467-77. PubMed ID: 15107602
[TBL] [Abstract][Full Text] [Related]
8. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy.
Ben-Dor I; Kleiman NS; Lev E
Am J Cardiol; 2009 Jul; 104(2):227-33. PubMed ID: 19576352
[TBL] [Abstract][Full Text] [Related]
9. Thienopyridines in cardiovascular disease: focus on clopidogrel resistance.
Siller-Matula J; Schrör K; Wojta J; Huber K
Thromb Haemost; 2007 Mar; 97(3):385-93. PubMed ID: 17334505
[TBL] [Abstract][Full Text] [Related]
10. Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination.
Cooke GE; Liu-Stratton Y; Ferketich AK; Moeschberger ML; Frid DJ; Magorien RD; Bray PF; Binkley PF; Goldschmidt-Clermont PJ
J Am Coll Cardiol; 2006 Feb; 47(3):541-6. PubMed ID: 16458133
[TBL] [Abstract][Full Text] [Related]
11. Use of clopidogrel in coronary artery disease.
Sureddi RK
J Ark Med Soc; 2007 Feb; 103(8):201-3. PubMed ID: 17436832
[TBL] [Abstract][Full Text] [Related]
12. Role of antiplatelet therapy across the spectrum of patients with coronary artery disease.
Bhatt DL
Am J Cardiol; 2009 Feb; 103(3 Suppl):11A-19A. PubMed ID: 19166708
[TBL] [Abstract][Full Text] [Related]
13. Variability in platelet response to the antiplatelet agents aspirin and clopidogrel: mechanisms, measurement, and clinical relevance.
Jennings LK
Crit Pathw Cardiol; 2009 Mar; 8(1):20-8. PubMed ID: 19258834
[TBL] [Abstract][Full Text] [Related]
14. Desensitization for the management of clopidogrel hypersensitivity: initial clinical experience.
Walker NE; Fasano MB; Horwitz PA
J Invasive Cardiol; 2006 Jul; 18(7):341-4. PubMed ID: 16816444
[TBL] [Abstract][Full Text] [Related]
15. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
Béres BJ; Tóth-Zsámboki E; Vargová K; László A; Masszi T; Kerecsen G; Préda I; Kiss RG
Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527
[TBL] [Abstract][Full Text] [Related]
16. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk factors for aspirin and clopidogrel resistance in patients with coronary artery disease or ischemic cerebrovascular disease.
Kim H; Lee HK; Han K; Jeon HK
Ann Clin Lab Sci; 2009; 39(3):289-94. PubMed ID: 19667414
[TBL] [Abstract][Full Text] [Related]
18. Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.
van Werkum JW; Topcu Y; Postma S; Kelder JC; Hackeng CM; ten Berg JM; Verheugt FW
Thromb Haemost; 2008 Mar; 99(3):637-9. PubMed ID: 18327417
[No Abstract] [Full Text] [Related]
19. Clinical implications of clopidogrel resistance.
De Miguel A; Ibanez B; Badimón JJ
Thromb Haemost; 2008 Aug; 100(2):196-203. PubMed ID: 18690337
[TBL] [Abstract][Full Text] [Related]
20. Role of antiplatelet therapy in cardiovascular disease III: Peripheral arterial disease.
Cavendish JJ; Safani M
Curr Med Res Opin; 2004 Nov; 20(11):1851-5. PubMed ID: 15537486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
